1 unknown. 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 1 | Unknown 1 |
Follow Hyperlipoproteinemia Type III: new trials by email Literature Review of Hyperlipoproteinemia Type III trials Research Report on Hyperlipoproteinemia Type III
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effects of Evolocumab Versus Placebo Added to Standard Lipid-lowering Therapy on Fasting and Post Fat Load Lipids in Patients With Familial Dysbetalipoproteinemia Evolocumab Auto-Injector [Repatha], Placebos - Familial Dysbetalipoproteinemia, Hyperlipoproteinemia Type III | Phase 4 | Unknown | UMC Utrecht | 30 | 2019-08-01 | 2019-01-22 |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Dyslipidemias (1) · Genetic Diseases, Inborn (1) · Hyperlipidemias (1) · Hyperlipoproteinemias (1) · Lipid Metabolism Disorders (1) · Lipid Metabolism, Inborn Errors (1) · Metabolic Diseases (1) · Metabolism, Inborn Errors (1) · Nutritional and Metabolic Diseases (1)
evolocumab (1)
UMC Utrecht (1)